Related Experiment Video
Updated: Sep 14, 2025

Real-Time Assessment of Spinal Cord Microperfusion in a Porcine Model of Ischemia/Reperfusion
Published on: December 10, 2020
Macrovascular Hemodynamics and Peripheral Perfusion in Cardiogenic Shock: Exploring Current Targets and Future
Leah B Kosyakovsky1, William B Earle2, Colter Wichern2
1Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Insights
Cardiogenic shock (CS) has high mortality. This review highlights microvascular tissue perfusion markers as promising tools for better management and prognosis in CS patients, addressing limitations of current macrovascular-focused therapies.
Area of Science:
- Cardiology
- Critical Care Medicine
- Hemodynamics
Background:
- Cardiogenic shock (CS) continues to have high mortality rates, necessitating improved prognostic tools and therapeutic strategies.
- Current CS management primarily focuses on macrovascular metrics, assuming synchronized macro- and microvascular responses to interventions.
- Emerging evidence indicates a potential dissociation between macrovascular and microvascular function in critically ill patients.
Purpose of the Study:
- To review the significance of macrovascular and microvascular metrics in cardiogenic shock.
- To highlight the role of microvascular tissue perfusion markers in CS management.
- To summarize the current understanding of microvascular dysfunction in CS.
Main Methods:
- Systematic review of existing literature on cardiogenic shock pathophysiology and management.
- Analysis of studies comparing macrovascular and microvascular parameters in CS.
- Synthesis of evidence on the utility of microvascular perfusion markers.
Main Results:
- Macrovascular and microvascular circulatory functions may not always align in critical illness, particularly in CS.
- Microvascular dysfunction significantly contributes to CS pathophysiology.
- Microvascular tissue perfusion markers show promise for improved patient management.
Conclusions:
- Microvascular tissue perfusion assessment offers a valuable adjunct to traditional macrovascular monitoring in CS.
- Further research into microvascular dynamics can lead to more targeted and effective CS therapies.
- Optimizing microvascular function is crucial for improving outcomes in patients with cardiogenic shock.
Abstract:
Despite significant advances in care over the past few decades, mortality among patients with cardiogenic shock (CS) remains up to 50%. Given the persistently high mortality, there is an urgent need for both better prognostic tools and treatment strategies. The pathophysiology of CS has major contributions from both macrovascular and microvascular dysfunction, but therapies are titrated toward the more readily measurable metrics (ie, mean arterial pressure, cardiac index, etc) under the assumption that both macrovascular and microvascular dynamics will respond to intervention in tandem. However, emerging evidence suggests that macrovascular and microvascular circulatory functions are not always aligned, particularly in those with critical illness. This review summarizes the significance of different macrovascular and microvascular metrics in CS, drawing from a robust field of evidence to demonstrate the promising role that microvascular tissue perfusion markers play in management of patients with CS and summarize the current understanding of this burgeoning field.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Pathophysiology of Cardiac Performance
Heart Failure II: Pathophysiology